T1	Participants 82 117	WHO type I anovulation infertility:
T2	Participants 749 763	women with HH.
T3	Participants 835 884	35 HH women (aged 25-36 yr) attending our Center.
T4	Participants 885 1010	Eighteen patients received 150 IU hMG-HP (150 IU FSH + 150 IU LH-like activity) and seventeen received 150IU r-hFSH/75IU rhLH
T5	Participants 1858 1875	development in HH
